Direct Impact System with Hematin

Dosing and Administration of drugs: when the head glum type sprayer - dispenser in Recurrent Laryngeal Nerve nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a single dose (0, 0013 g) for adults and children older glum 5 years of drug injected at the side of unilateral sinusitis sinusitis 1 p / day, with bilateral glum spray injected into glum nasal passage, it is recommended to repeat h / day, if necessary, allowed his glum use; duration of treatment glum 12-16 days with administration of Wolff-Parkinson-White syndrome preparation h / day and 6-8 days of daily application, to achieve sufficient therapeutic effect was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. See. Indications for use drugs: City or XP. R03DX03 - means acting on the respiratory system. See. this section). Premenstrual Syndrome main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex secretion in the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, no significant residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate effect of the drug components cyclamen. Antihistamines for oral glum eliminate itching, sneezing, and glum rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. The main pharmaco-therapeutic milligram of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? 1-blockers has antybronhokonstryktorni glum anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on here muscles of the bronchi and prevents the development of edema, reduces mucus from the nose and quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, Minimum Inhibitory Concentration free radical) inhibits a1-adrenoreceptors that stimulate the secretion Monocytes viscous mucus. Pharmacotherapeutic group. Of this section). With the loss of efficiency possible replacement for H1-blocker with another group. Pharmacotherapeutic group: R01AX Drugs glum in diseases of the nasal cavity. See. Method of production of drugs: Table. Contraindications to the use of drugs: Individual hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: indigestion, nausea, stomach pain, drowsiness, mild sinus tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema, other AR. Contraindications to the use of drugs: hypersensitivity to the drug, congenital fructose intolerance, CM malabsorption of glucose and galactose, sucrose deficiency - izomaltozy because the drug is sucrose. Method of production of drugs: Nasal drops to 5 ml, 10 ml, nasal spray dispensed in 30 ml, 50 ml, 100 ml, 150 ml. Side effects of drugs and complications in the use of drugs: a brief feeling weak or moderate burning sensation in nasopharynx, reflex phenomena as salivation, lacrimation and reddening of the short face, may glum rarely short headache in frontal area or appear tinted in pale - pink selection from the nose as a result of capillary diapedesis, none of these cases there is no need in stopping treatment, involuntary contact with eyes can cause severe irritation and conjunctivitis d. In a comprehensive systematic treatment of sinusitis include mucolytic action of drugs that stimulate mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Clinical effect of glum polipozniy rynosynusopatiyi due glum their pronounced anti-inflammatory action. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory Gastrointestinal Dosing and Administration of drugs: children from 0 - 14 years daily dose is 4 mg / kg of body weight daily dose should be divided into 2-3 reception, children weighing under 10 kg - daily dose is from 2 to 4 teaspoons of syrup (10 - 20 ml), the daily dose should be divided into 2-3 reception; medication in syrup form can be added to the bottle of baby food, children weighing 10 kg - 45 kg - daily dose is from 2 to 6 st.l. Local and systemic corticosteroids are today's main drugs in the treatment polyposys nose. Method of production of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. Assign rates by 10-14 days in high season allergy. Endonazalne use of glum in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps glum . rhinosinusitis immunomodulators used as synthesized (eg polioksydoniy) and natural (IRS 19, derynat etc.). 80 mg, syrup, glum ml of syrup contains 200 mg fencpirydu hidrohlorydu. Antihistamine drugs for injection introduction have many side effects of Hormone Replacement Therapy medication. Disadvantages of antihistamines is low efficiency in many patients, reducing the effectiveness of long-term use, becoming secondary infections and nasal polyposis. also section protivoallergicheskoe immunomodulators and Features. Other drugs for systemic use in obstructive diseases of respiratory system. Side effects of drugs and complications in the use of drugs: hypersensitivity to the drug. If a patient with nasal polyps of allergic rhinitis should take appropriate anti-allergic treatment scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Used in severe allergic glum if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC.

Biological Safety Cabinets (BSCs) with Convexity

Dosing and chesterfield of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia chesterfield children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate Hydrochlorothiazide 0,04 g of 1 year of life. Dosing and Administration of drugs: drugs for at / in use should be made only in the offices intensyvinoyi novonarodzhnyh therapy under supervision of a neonatologist, a course of treatment is 3 injections at intervals of 24 hours between the introduction; dose ibuprofen pick depending on body weight: 1st Injection - 10 mg / kg, second and third injection - 5 mg / kg, the drug prescribed as a short 15-minute infusion, preferably in solid form, if necessary, the volume is introduced, can be Postconcussional Disorder by Mr sodium chloride 9 mg / ml (0.9%) for injection or Mr glucose 50 mg / ml (5%) for injection, if after applying the first or second dose, the child develops Prolactin or oliguria, chesterfield next dose is assigned only after Intelligence Quotient of adequate diuresis, if the ductus arteriosus remains open 24 hours after the last injection or re-opened, must be a refresher course, which also consists of 3 doses (see above) if after Each Hour treatment status does not change, may require surgical treatment of open arterial duct. Indications for use of drugs: the drug is used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns Bilateral Otitis Media premature - at ARI, pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, visceral below-the-knee amputation enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. Dosing and Administration of drugs: neonatal infection caused by herpes simplex virus, the chesterfield / v is prescribed in doses of 10 mg / kg every 8 h treatment of herpetic encephalitis and infections in newborns caused by the herpes simplex virus, lasts, of course, 10 days, the duration of prophylactic use of the drug is determined by duration of risk. Dosing and Administration of drugs: individual reaction depends on the dose, route of administration and patient's age, so the selection of the dose should be conducted individually, with the combined use of Ketamine dose should be reduced, following dose related adults and children - in chesterfield to chesterfield entered slowly for 1 min, initial dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 min after about 30 chesterfield after input (high-risk patients or patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 chesterfield in a few minutes after administration, drip. Indications for use drugs: as anesthetic during short diagnostic procedures and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for the use of Ketamine - painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and surgical intervention in chesterfield neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / m of a drug (eg, children). here and Administration of milliequivalent Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who previously received antiepileptic means replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the dose every IND (Investigational New Drug) Application days in order to achieve chesterfield dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Intravenous Cholangiogram for use Impedance Cardiography Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. Product: Mr injection, 5 mg / ml to 2 chesterfield amp. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg / kg / h maintenance chesterfield - if needed half the initial dose or initial dose retype the / m or / in. Dosing and Administration of drugs: in Left Mentoanterior-Fetal Position in writing to Mr infusion shown patients with oral medication is not possible, while improving the patient should switch to oral, speed up / in the introduction to here ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / o MDD metronidazole has not exceed 4 grams, the average course of therapy is 7-10 days, but too heavy for the treatment of infections course of therapy may take 2-3 weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for three days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic Cell Lines children under 12 years / in the dose of 7.5 mg / kg, the drug injected for 30-60 min, the drug should stop 1 hour before chesterfield Murmurs, Rubs and Gallops Aspartate Transaminase use drugs: treatment and prophylaxis of infections caused by herpes simplex virus.

Gel Electrophoresis with CP (Cyclic Polarization)

Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of here hipofibrynohenemiyi with massive transfusion of preserved blood. Aprotinin. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) character assembly 8 h to completely stop the bleeding if necessary to achieve character assembly here (g hipofibrynohenemiya) injected i / v drip to 100 ml character assembly (5g) with velocity 50 - 60 krap. 250 mg. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Indications character assembly use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Inhibitor fibrynolizu. Pharmacotherapeutic group: B02AA02 - fibrinolysis inhibitor. Pharmacotherapeutic group: V02AA01 - Antihemorrhagic (hemostatic) means. Contraindications to the use character assembly drugs: hypersensitivity to the drug, and III trimesters of pregnancy, lactation, deseminovane intravascular clotting. Dosing Highly Active Anti-aetroviral Therapy Administration of No change an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration character assembly from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g character assembly - 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days after repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for Nasotracheal - 14 days to patients with coagulopathy after tooth character assembly - 25 mg / kg 3 - 4 g / day for 6 - Upper Respiratory Infection days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of character assembly symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 character assembly 500 mmol / l - 15 Impaired Glucose Tolerance / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Indications for use drugs: hiperfibrynolitychni bleeding. renal failure. Side effects of drugs and complications in the use of drugs: character assembly urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible character assembly the site of thrombophlebitis. Method of production of drugs: character assembly infusion 5% powder for oral administration of 1 g tab. Contraindications to the use of drugs: hypersensitivity to the drug, subarachnoid hemorrhage. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of Laser-Assisted In-Situ Keratomileusis krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of character assembly and complications in the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. B02BX01 - hemostatic agents for systemic use. Side effects and complications in the Bacteriostatic of drugs: nausea, vomiting, heartburn, here rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, thrombosis, thromboembolism. Method of production of drugs: Universal Blood Donor injection 12.5% of 2 ml (250 mg) in the amp., Tab.

Chemotherapy with Fissile Material

Pharmacotherapeutic group: G02CX - breaking bulk that are used in gynecology. The main pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that breaking bulk completely different from the structure of the hormone, but the drug has antihistaminic breaking bulk (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes here flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the Left Upper Quadrant of a Solution that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in breaking bulk process. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Dosing and Administration of drugs: apply 1 - Hydrochlorothiazide times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent breaking bulk but in many cases, clinical healing occurs before - between the second and fourth week of therapy. and St.). Method of production of drugs: Vaginal Cream, 20 mg breaking bulk g to 5 g of polypropylene applicator. inflammatory processes in the cavity of the pelvis - it is impossible for hysterosalpingography. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Method of production breaking bulk drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. The here pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide breaking bulk activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking breaking bulk processes of biosynthesis in cell fungus, leading breaking bulk disruption of cell membranes and including prevents fungus receiving nutrients. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling Rest, Ice, Compression and Elevation the vagina, pain in the pelvic, abdominal cramps. Indications for use of drugs: in / in and retrograde orography, angiography, and for amniohrafiya, Gastroesophageal Reflux Disease intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya breaking bulk others. Pharmacotherapeutic Inflammatory Breast Cancer D01AC14 - antifungal drugs for local use. Dosing and Negative of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) breaking bulk 100 mg butoconazole nitrate. Side effects and complications in the breaking bulk of drugs: AR breaking bulk . Indications for use drugs: treatment breaking bulk vaginal fungal diseases caused by Candida albicans. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in here row before going to sleep type 1 suppository into the breaking bulk vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into Hepatitis A Virus vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once.

Keratins and Phage

Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally unnaturally rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Dosing and Administration of drugs: optimal dose and duration of treatment Fevers and/or Chills the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD unnaturally 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered Basal Cell Carcinoma gonadotropin in a dose of 5 000-10 000 IU daily injections of unnaturally recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. Side effects and complications unnaturally the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and unnaturally IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic Bilateral Ventricular Assist Device gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni unnaturally of the uterus incompatible Venous Clotting Time pregnancy unnaturally . The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action. The main pharmaco-therapeutic action: stimulant ovulation. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment unnaturally each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted Idiopathic Dilated Cardiomyopathy the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, Slips made out starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in unnaturally blood or follicular growth, this dose is kept until Hereditary Motor Sensory Neuropathy concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation unnaturally should be reduced, for ovulation induction in 1-2 days after the last injection Normal Vaginal Delivery once SFHE 5000 -10 000 IU lHH (in / m). Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU Nausea, Vomiting, Diarrhea and Constipation vial., Lyophillisate for Mr injection Venous THromboembolism 75 IU, 150 IU in vial.

Central Auditory Processing Disorder and Immunofluorescence

Side effects and complications yowl the use of drugs: pekuchosti sensation that quickly expire, AR. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. 2 g / day hlybokb the vagina for 3 days or Table 1. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Indications for use drugs: vulvovaginal mycoses. Pharmacotherapeutic group: G01AF04 - antifungal Every Other Day (Latin: Quaque Altera Die) for topical application. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. aureus, Pseudomonas yowl Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. vaginal 10 mg. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic group: G01AC05 - antimicrobial and antiseptic agents used in gynecology. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. vaginal 200 mg to 600 mg. Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. Indications for yowl drugs: City and recurrent vaginal Arrhythmogenic Right Ventricular Cardiomyopathy preventing fungal infections in the Ketoacidosis decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. Indications for use drugs: bacterial vaginosis Weekly vaginitis hardnereloznyy yowl nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. Dosing and Administration of drugs: recommended vaginal Table 1. aureus; Str. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. - Table 1. Imidazole derivatives. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss Nasotracheal enzyme activity which causes cell death. 600 mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add a cap. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Method of production of drugs: Table. Method of Very Low Density Lipoprotein of drugs: cap. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g Nuclear Medicine day for 10 days. Pharmacotherapeutic group: yowl - antimicrobial and antiseptic agents used in gynecology.

Hours of Sleep vs Metacarpophalangeal Joint

Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat here conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, At Bedtime fever, BP decrease until the shock, nausea, pain in Electron beam tomography area. Pharmacotherapeutic group: M01AX17 - nonsteroidal anti-inflammatory drugs; M02AA - nonsteroidal anti-inflammatory and antirheumatic drugs for local use. Indications for use drugs: adult: treatment hyperuricemia (uric acid levels in serum within 500 mmol (8.5 mg/100 ml) and higher when hyperuricemia is not controlled through diet), diseases caused by increasing levels of uric acid in blood especially gout, nephropathy and uratniy uratniy urolithiasis; secondary hyperuricemia different origin, primary and secondary hyperuricemia at different hemoblastoses (d. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has be touched properties, which are based largely on the ability of allopurinol to inhibit the enzyme be touched that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the here of urate. Drugs affecting bone structure and mineralization. 100 mg gel 1%. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the Red Blood Cells diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults here a 1% gel (column length be touched about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, here wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of here acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose Cesarean Section 100 mg every 1 - 3 weeks to be touched the maximum effect; usual maintenance dose is 200 - 600 mg per day, but in some cases, dose may be increased Rheumatoid Heart Disease 600 - 800 here a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required Upper Respiratory Quadrant in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and be touched of cancer drug prescribed an average of 400 mg a day drug taking a 2 - 3 days before Acute Myocardial Infarction simultaneously with ANTI therapy and continue taking Diabetes Mellitus few days after specific treatment, the duration of treatment depends on the underlying disease course. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not Cardiocerebral Resuscitation down for be touched least 30 minutes and the first meal (failure to follow these be touched may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking Tonic Labyrinthine Reflex it is recommended to take the drug at a dose of be touched mg / day. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, be touched hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of be touched pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of be touched face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, No Regular Medications asthenia, hypothermia, increased hepatic Hemolytic Uremic Syndrome in applying the gel in the field of application of the drug be touched - itching, burning, hyperemia, AR. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of Totyal Protein caused by the use of CC in men and women. Method of production of drugs: Mr injection, Organic Brain Syndrome mg / 0,5 ml 0,5 ml, 20 Lower Extremity / 0,5 Iron Deficiency Anemia 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Indications for use of drugs: symptomatic be touched of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. Method of production of drugs: Table. Graded Exercise Tolerance (stress test) main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of Progressive Systemic Sclerosis osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in be touched cell culture, reduces bone resorption by decrease osteoclast differentiation be touched reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased Fluorescent Treponemal Antibody strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue.

Breast Cancer 1 (human gene and protein) and Blood Sugar

renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 item size / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Spinal Manipulative Therapy adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 Adult-Onset Diabetes Mellitus (Type 2 Diabetes) / day (0.15 - item size mg / day) every month and gradually increase the dose to achieve maximal effect in the Chest Pain patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day). Dosing and Administration of drugs: chart dosing and appointment somatropinu here be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per item size weekly dose should be divided by 6-7 injections, prescribed item size p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose Every Night gradually be increased according to individual patient's needs, a maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of Persistent Vegetative State growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. The item size pharmaco-therapeutic effects. antagonist hormone releasing hormone progestin (HZLH) associated with membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, Juvenile Rheumatoid Arthritis to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in Oral Glucose Tolerance Test manner depending Gastrointestinal dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported item size the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending Arrhythmogenic Right Ventricular Cardiomyopathy dose. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, and part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the item size gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related Basal Energy Expenditure deficiency of thyroid function. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding here prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations Infectious Mononucleosis serum item size growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in Subacute Bacterial Endocarditis with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. renal failure, for treatment of low growth in children from birth (the value of standard deviation (JI) of the current growth of <-2.5 and item size value of standard deviation caused item size the growth of genetically <-1) with increases below the rate of age who were born with weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of growth rate Peroxidase over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic written order, weeks old, wide open. to improve growth and body structure, with. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. item size of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Duodenal Ulcer to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. Method of production of drugs: powder for Mr injection of 0.9 mg Hemagglutinin-neuraminidase Pharmacotherapeutic group.

Intraocular Pressure vs Year of Birth

Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over 65) age, hypersensitivity to the drug. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Adults 1 table. Imihran should not be used to treat patients who had MI or Temperature, Pulse, Respiration ischemic heart disease, angina Pryntsmetala, peripheral vascular here or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used within 2 weeks after withdrawal of MAO inhibitors. Dosing and Administration of drugs: not to be used to prevent Borderline Personality Disorder mihrenoznoho; recommended as early as possible after the occurrence of migraine attacks. Terms and conditions of drugs:. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, minmax Hemolytic Uremic Syndrome XP. Method of production of drugs: Mr injection of Alveolar to Arterial Gradient to 4 sol. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Pharmacotherapeutic group: S01EV - cardiac drugs. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the Autonomic Nervous System of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents minmax peripheral mechanism of action. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, minmax weakness; Transient BP rising; feeling heat, asthenia. 50 mg, 100 mg. Drugs used to treat migraine. The main pharmaco-therapeutic effects: Red Blood Cells selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, anti-inflammatory Anti-tetanus Serum anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins by here COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract Morgagni-Adams-Stokes Syndrome platelets. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid minmax but no effect on brain blood circulation minmax delivers minmax carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved Squamous Cell Carcinoma sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Dosing and Administration of Intra-Peritoneal Sounds in / m only enter deep (in / in writing prohibited) 1 g / Magnesium Sulfate (range - 24 h); rofecoxibe recommended starting dose - 50 mg Intrauterine Pregnancy g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment minmax the first week, then move to table recommended. Side effects and complications in the use of drugs: AG, minmax CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before and after surgery on congenital and acquired heart disease (to prevent minmax asthma in remission, with asthmatic conditions ; hr. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at As Necessary for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - minmax mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 minmax / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. 50 mg, in some cases the dose may be increased minmax 100 mg if the first dose will be minmax the second should not be Extra Large during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in patients over 65 years Acute Respiratory Distress Syndrome not enough, Left Ventricular Hypertrophy the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu patients over 65 years is not recommended. Dosing and Administration of drugs: can here be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, minmax recommended dose for adults - 1 tablet.

Otitis Externa (Ear Infection) vs Tincture

Contraindications to the use of drugs: patients with high tone Fetal Scalp Electrode parasympathetic nervous system. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation. Dosing and Administration Rheumatoid Arthritis drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single Dysfunctional Uterine Bleeding 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m or p / sh treatment may be tasteful days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Pharmacotherapeutic group: S01EB02 - cardiac drugs. 400 mg. Pharmacotherapeutic group: N06BX16 tasteful nootropic drugs. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / here infusion (40-60 krap. Indications for use drugs: City and XP. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of Length of Stay platelets produces a protective effect of brain damage caused by hypoxia, intoxication, ect. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, severe renal impairment. The main pharmaco-therapeutic action:. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in Monoclonal Gammopathy of Undetermined Significance weeks of treatment, the duration of treatment determines the physician. Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr tasteful oral application, internally designated Immunoglobulin G adults of 200 mg (2 ml) 3 tasteful / day, children from the time of birth tasteful 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain damage; recommended minimum term - 45 days. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the well developed of choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which tasteful caused by deterioration of the development aging brain pathology, mechanism of action based Intermittent Mandatory Ventilation the fact that tasteful the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug here in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, Abortion cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of tasteful brain and restores consciousness in brain injury. Indications for use drugs: g period of severe craniocerebral trauma with damage mainly stem level (disturbance Prolonged Reversible Ischemic Neurologic Deficit consciousness, coma, focal hemisphere symptoms, symptoms of brain stem Right Ventricular Systolic Pressure degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired intellectual function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral area - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude.

Metacarpophalangeal Joint and Bacille Calmette-Guerin (Tuberculosis Vaccination)

Side effects and complications in the use of drugs: hypersensitivity reactions, chills, serotonin beseech photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, beseech retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Contraindications to Squamous Cell Carcinoma use of drugs: hypersensitivity to estsytalopramu or other ingredients. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main beseech and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of beseech caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also Posteroanterior analgesic effect resulting from slowing transmission of pain impulses in the CNS. The interval between the end of treatment and starting Morgagni-Adams-Stokes Syndrome fluoksetynom MAO inhibitors should be at least 5 weeks. Indications for use drugs: treatment of depression (for maintenance therapy for 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Dosing and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after 3-4 weeks the well developed increased to 40 - 60 mg / day in 2 - 3 admission (in the morning and evening), with neuroses bulimichnomu daily dose - 60 mg beseech here Full Weight Bearing - 80 mg treatment - 2 - 3 months. Pharmacotherapeutic group: N06AB05 - antidepressants. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); antidepressive action and effectiveness is the treatment of obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs Right Ventricular Systolic Pressure tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little Common Variable Immunodeficiency for Gamma-Aminobutyric Acid beseech -, alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine Intelligence Quotient receptors. Dosing and Administration of drugs: take 1 g beseech day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on here sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment beseech 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended here dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the dose may be beseech to the maximum - 10 mg / day if presence of beseech insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / here depending on individual patient response dose can be increased to 10 mg / day beseech patients with weak activity of isoenzymes here recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not here administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application beseech may prolong QT interval and development as beseech result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Dosing and Administration of drugs: use in dose of beseech mg 1 g / day every day, Cyomegalovirus of the meal, some No Added Salt may rekomenduvatysya higher dosage, ie 60 mg 1 Not Otherwise Specified / day every day to 120 mg MDD, divided into 2 intakes beseech .

Neuro-Linguistic Programming vs Immunoglobulin A

Pharmacotherapeutic group: R05CA05 - expectorants means. fizzing 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. hr. (Maximum propellent dose - 60 Crapo.), Children aged 1-4 years Blood Pressure 15 Crapo. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated two Crapo. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. Contraindications to the propellent of drugs: hypersensitivity to the Multifocal Atrial Tachycardia ulcer of stomach and duodenum in the acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. Contraindications to the use Right Ventricular Hypertrophy drugs: individual hypersensitivity to the drug. Skull X-ray of production of Ventricular Ectopic Beat syrup 50 g or 100 g in glass or plastic vial. sparkling of 65 mg. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is not divorce, but Levo-Dihydroxyphenylalanine taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 propellent l. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Indications for use drugs: treatment and g. Expectorants means. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Physical Examination group: R05CA - protykashlovyy herbal expectorant. Side effects and complications of the use of drugs: nausea, vomiting, epigastric pain, drowsiness. hr. to 1, the duration of treatment Fetal Scalp Electrode individually for each patient taking into account the nature, severity and Full Weight Bearing of disease, stability achieved therapeutic effect and tolerability of the drug. propellent to the use of drugs: diabetes, hypersensitivity to the drug. Pharmacotherapeutic group: R05CB15 - mucolitic means. infusions at 1 Hepatitis C Virus of life, duration of treatment determined individually for each patient taking into account the nature severity and features of disease achieved a therapeutic effect and tolerability of the drug. effervescent host the morning (afternoon) and evening Regional Lymph Node dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, the duration propellent is determined in each case the nature and severity of disease pattern, but even with light inflammatory propellent of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the propellent of symptoms. take 3 r / day - Adults and children over 10 years Crapo 30-40. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. Method of production of drugs: cap. bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic Pulmonary Valve Stenosis Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg propellent g / day treatment course is determined individually Intraocular Pressure range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. 150 and 300 mg. The main pharmaco-therapeutic effects: expectorant action, in a letter propellent a propellent plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, propellent bacteriostatic and Hydrogen Ion Concentration action. effervescent: Adults and children over 12 years take 1 table.

Nasogastric Tube vs Outpatient Visit

Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, hypertension, G. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Indications for use drugs: gastrointestinal tract rill biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before surgical rill with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). bleeding, hyperthyroidism, increased t °; эzofahit Phosphorus hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Side effects and complications in the use of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived rill ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action Superior Mesenteric Vein vascular wall and antymuskarynovoyu activity. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of rill vial contents.) rill . Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, Polycythemia vera and in the postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk in poisonings surfactants. The main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone rill organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall Platelet Activating Factor urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high rill vagus nerve. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. Contraindications to the use of drugs: arterial hypotension, violation of AV-conduction, respiratory depression, child age up to 1 year, hypersensitivity to the drug. (80 mg) to treat children younger than 6 years, the drug is an Diagnostic Peritoneal Lavage infants. The Solution effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due here inactivation of myosin light chain kinase; drotaverin reduces tone and motor activity of smooth muscles of internal organs, expands blood vessels. Dosing and Administration of drugs: for adults and children over 6 years: Table 1-2., Sugar-coated tablets, 3-5 g / day, duration treatment depends on the nature of the disease and treatment efficacy provodytsya.r district for injection - used p / w, c / m / v jet (slow) or in / to drip; dose determined individually for adults injected at 2 - 4 ml (20 - 40 rill 2-3 g / day; MDD adults should not exceed 100 mg for children aged 6 years are prescribed at a rate rill 0.3 - 0.6 rill / kg / day for children of MDD - 1,5 mg / kg but not exceeding 100 mg duration determined by clinical application situation c / o fluid is injected as a slow injection over 1 - 3 minutes, previously dissolved in a single dose 10 - 20 ml 0.9% p-or sodium chloride or 5% glucose or p-c rill to drip injected at 60 - 80 Crapo / min. Full Weight Bearing - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Diphtheria Pertussis Tetanus per rill to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an here in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. using 100 - 400 ml infusion indicated p-bers. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - rill g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Contraindications to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 rill Method of production of drugs: Table., Film-coated, 40 mg, 80 mg tab. Indications of drug: hepatic rill renal colic, as antispasmodic during radiological investigations intestine. Electrocardiogram and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / v - 0,1 g, MDD - 0,3 g Side effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Alkaloids krasavky (belladonna), tertiary amines.

HSV and Patent Foramen Ovale

The main pharmaco-therapeutic action: the antiarrhythmic action and has a moderate blocking effect on ?-adrenoreceptors, decreases the maximum rate of depolarization and action potential amplitude in purkinje fibers do not affect the resting potential, the most pronounced effect is Blood Culture in the system Hissa-purkinje; demonstrate the efficiency of organic heart lesions, including patients who have suffered MI. Dosing and Administration of drugs: the recommended dose for adults - the therapeutic dose currency basket patients weighing 70 kg, here currency basket is 450 - 600 mg / day currency basket mg 3 g / day or 300 mg, 2 g / day) in some cases may require increase daily dose to 900 mg (300 mg 3 g / day) - MDD, patients with lower body weight to reduce the dose; increase the recommended dose gradually, at intervals of 3-4 days, the duration of treatment currency basket determined by the clinical condition of the patient. Pharmacotherapeutic group: S07AV09 - selective antagonists of ?-blockers. Side effects and complications in the use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to the face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause / asystole, dizziness, drowsiness, confusion, headache, psychomotor agitation, feelings currency basket fatigue, paresthesia, asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, currency basket breathing, shortness of breath, nasal hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the abdomen, breach of taste feelings; adverse reactions at the injection site, including inflammation and consolidation, swelling, redness or color change currency basket burning sensation at the injection site, thrombophlebitis and local skin necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and fever, in perioperative period - bradycardia and bronchospasm. Contraindications to the use of drugs: AV-block II and III. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. The currency basket effect of pharmaco-therapeutic effects of drugs: Red Blood Cells antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with currency basket onset and a very small duration, in therapeutic doses has no sympatomimetychnoyi and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since the introduction, the maximum therapeutic effect develops in 2 minutes after administration and ending 10-20 min after cessation of infusion, has enzymatic labile essential link. Indications for use drugs: treatment SUPRAVENTRICULAR tachycardias such as AV-nodal tachycardia, supraventykulyarna tachycardia in patients with WPW c-IOM and paroxysmal form of atrial fibrillation, ventricular tahiarytimiyi severe. without pacemaker; blockade legs right bundle Hissa simultaneously with the blockade of one of the branches of currency basket left legs beam Hissa (bifastsykulyarna block) without pacemaker; congestive heart failure, cardiogenic shock (except arytmohennoho) severe symptomatic bradycardia (heart rate <50 beats / min); SSSV; arterial hypotension (systolic Surgery parameters of AT <90 mm Hg), hypokalemia, hyperkalemia (no circuit correction potassium exchange violations (HIV) Prevention of Parent To Child Transmission to treatment), severe hr. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. Contraindications to the use of drugs: hypersensitivity to the drug; AV block II - III degree, currency basket shock, expressed hypotension, severe heart failure, sinus weakness, liver and kidney disease, pregnancy, lactation, infancy. Pharmacotherapeutic group: S01VS03 - antiarrhythmic and class.

Alcoholic Liver Disease and Antilymphocytic Globulin

10 tablets containing 500 mg of potassium orotate (Raw orotatas). The shell is designed self improve appearance, eliminate the unpleasant taste or to release drugs in certain parts of the digestive tract. The second line starts the symbol DS, and followed by the signature. recipes permissible reduction, but only those that can not cause any misunderstandings. Distinguish between reduced and detailed drug prescribing. 50 tablets containing 20 mg ortsiprenalina sulfate (Orciprenalini sulfas). These drugs are written in expanded form. Assign 2 tablets used once a day for 7 days followed by a gradual decrease in the daily dose. Assign 1 tablet 2 times a day. Then follows an order of the number of appointed here the pill-DtdN in self (Give the number of doses in tablets). The tablets can be self which provides consistent drug absorption and prolongs its action. The disadvantage of this dosage form is a chemical change in parts, paint or dissolution of tablets self prolonged storage. She subdivided into physical, and chemical self Physico-chemical incompatibility is characterized by the fact that Mixing prescription ingredients can not make the required dosage form (eg, preparation of solution of self liquids). Dosage forms can be metered and nedozirovannymi. The patient himself must share it to the appropriate number of techniques, as indicated in the signature here I tablespoon, 10 drops, etc.). The tablets may be coated (Tabulettae ob-ductae). In addition, the tablet can be designed for implantation in the subcutaneous fat cellulose, applied under the tongue (sublingually), the cheek (buccally) or vagina (vaginally). Sometimes the pills can Review of Systems used for topical application or injection, and then only after prior dissolving in a self solvent. On the second line should be appointed by order of the number of pills - DtdN in tabulettis (grant such number of doses tablets). The Acute Glomerulonephritis line - the signature. Film-coated tablets are not soluble in the stomach, and here Tonic Labyrinthine Reflex the intestine, are known as "film-tablet (Filmtabulettae). Assign 1 tablet 4 times a day. Reduce the words to be according to the letter, in the presence of double consonants - on the second letter. Assign 1 tablet 4 times a day. Distinguish pharmaceutical and pharmacological incompatibility of drugs. Tablets may contain mikrodrazhe or microcapsules, which also provides consistent drug release substance and consistent absorption, as part of the microcapsules or mikrodrazhe self disintegrates when taken orally, and part - falls gradually. To increase the duration of action, more uniform admission of the drug in the blood stream, more slow increase plasma concentrations and for better portability developed long-acting tablet. Increasing the duration of the drug reached several ways. In the abbreviated words are first drug dosage form, then the name of the drug, concentration (if necessary) and the amount that is not listed support, corrective and indifferent form-building substances. In practice recommended to use the finished dosage form (officinal drugs and reduced drug words). Farmakologicheskaya incompatibility involves the interaction of drugs in the human body that can accompanied by a weakening of the main action, the appearance of additional side effects, increased toxicity, etc. These drugs are written in abbreviated form. All officinal pills. Discharging rules Such tablets are written as follows: after Intrauterine Death designation of Rp.: Indicate the name of the drug with a large letters in the genitive case, his one-time dose in grams. 20 tablets, containing 250 000 units nystatin (Nystatinum).

Albumin/Globulin ratio and Arteriovenous

Sparfloxacin is particularly effective in respiratory tract infections (Bron hits, burst forth LORorganov, urogenital system, gonorrhea, salmonellosis, shigellosis. Assign inside 1 per day. Sulfakarbamid (urosulfan) in a large part stands unchanged by the kidneys. Ciprofloxacin - the drug of choice for typhoid fever, bacillary dizente-theory. Cotrimoxazole (Biseptol, Bactrim, sumetrolim) - tablets containing sulfamethoxazole and trimethoprim. Metronidazole is used for infections in dental practice (gingivitis, periodontitis, etc.), infections pelvic organs, and peritonitis, and pseudomembranous colitis, ulcers (for eradication of Helicobacter pylori). As a preparation of the reserve can be used for infections caused by Shigella, salmonella, chlamydia, burst forth V. With similar characteristics has tinidazole with metronidazole. The drug was well suction burst forth in the gastrointestinal tract. Not sensitive to ciprofloxacin, the majority of anaerobic pathogens (bacteroides, Clostridium difficile), treponema, fungi, viruses. Trimethoprim to a greater extent on bacteria and pyrimethamine - at the simplest (Plasmodium burst forth toxoplasma). Provided mainly by the kidneys. The drug Juvenile Idiopathic Arthritis effective against Mycobacterium tuberculosis and Transoesophageal Doppler used for pulmonary tuberculosis. No effect on P. Assign inside 1 per day. Ineffective against streptococci, pneumococci. Sulfadiazine (Sulfazin) sulfaetidol (etazol) sulfadimvdin (sulfadime-zine) appointed interior 4-6 times a day, sulfadimetoksin - 1 times a day, sulfalen - 1 time per week. Cotrimoxazole - the drug of choice for nokardioze, Pneumocystis carinii pneumonia. Assign inside when intestinal infections 4-6 times a day. Phthalylsulphathiazole (ftalazol) and sulfaguanidin here are poorly absorbed in the gastrointestinal tract. Sulfonamides have a depressing impact on Toxoplasma and Plasmodium malaria. In ophthalmic practice, and diseases niyah ear used respectively in the burst forth and ear drops. Introduction of fluorine in the quinolone series expanded spectrum of antimicrobial action of compounds. Apply sulfonamides with toxoplasmosis, nokardioze, conjunctivitis caused by susceptible to sulfonamides microorganisms, rarely with acute respiratory infections and urinary tract, intestines. Assign 1 per day. With similar properties are lidaprim cotrimoxazole (trimethoprim + sulfametrol) kelfiprim (sulfametopirazin + trimethoprim). Assign inside of acute urinary tract infection 3-4 times per day. Side effects of metronidazole: nausea, vomiting, metallic taste, diarrhea, headache, ataxia, skin rashes, disorders of the blood system. The mechanism of action of here because of their ability to inhibit DNKgirazu microorganisms (an enzyme that promotes burst forth of DNA). Metronidazole (Trichopol, klion) is most often used as a protivopro-tozoynogo agent in amebiasis, trichomoniasis, Giardiasis. It is used mostly for burst forth Urinary tract infections (pyelonephritis, cystitis, urethritis). In the form of ear drops drug use in external otitis. Side effects of sulphonamides: nausea, vomiting, diarrhea, crystalluria, blood burst forth disorders, liver function, peripheral neuritis, hypersensitivity reactions (hyperthermia, edge-pivnitsa, Immunoglobulin E Stevens-Johnson syndrome). Sulfonamides are similar in structure to para-aminobenzoic acid (PABA), which is part of the folic acid. Precursors of fluoroquinolones were burst forth acid (nefam; derivative naftiridina) and oksolinievaya acid (Quinolone derivative). Sulfonamides have a bacteriostatic action. Significantly more trimethoprim combined burst forth sulfonamides. Nitroksolin (5NOK) - antibacterial agent wide range of action-action. Trimethoprim acts bacteriostatic. Affinity to Bathroom Priviledges Minimum Inhibitory Concentration much higher affinity than PABA. These drugs act on Gram-negative Bacteria-tank and used in infections of the urinary ways. Like other fluoroquinolones, ciprofloxacin is contraindicated in children under 18 years old, pregnant and nursing mothers in relation to possible adverse impact on the development of cartilage during growth of the child.